Beta-cell-derived urocortin-3 contributes to glucose-regulated somatostatin and glucagon secretion in the mouse pancreas
Aims/Hypothesis. Glucagon secretion is impaired in both type 1 and type 2 diabetes. The mechanisms behind this dysregulation are incompletely understood. Urocortin-3 (UCN-3), a beta-cell-derived peptide, stimulates somatostatin (SST) secretion and may thereby regulate glucagon secretion. We investigated the mechanisms through which UCN-3 regulates pancreatic hormone secretion and examined the physiological contribution of endogenous UCN-3 to glucose-regulated hormone secretion. Methods. Pancreatic hormone secretion was studied using the isolated perfused mouse pancreas. The effects of exogenous and endogenous UCN-3 were investigated using selective antagonists of SST receptors (SSTR) and corticotropin-releasing hormone receptor 2 (CRHR2). In addition, the role of UCN-3 was examined in streptozotocin (STZ) treated mice. Results. Exogenous UCN-3stimulated somatostatin secretion and inhibited glucagon secretion in the mouse pancreas. Blockade of SSTRs completely abolished the glucagonostatic effect of UCN-3, demonstrating that inhibition of glucagon secretion is indirectly mediated through SST signaling. Moreover, CRHR2 antagonism prevented both UCN-3-induced SST secretion and inhibition of glucagon secretion, identifying CRHR2 as the key receptor mediating these effects. During acute glucose stimulation (3.5-10mM), CRHR2 antagonism reduced glucose-induced stimulation of SST and attenuated glucagon inhibition, indicating that endogenous UCN-3 participates in the acute islet response to hyperglycemia. However, during sustained hyperglycemia, CRHR2 antagonism reduced SST secretion without altering glucagon secretion. In STZ-treated mice, glucose-induced SST secretion was lost. Conclusions. Urocortin-3 regulated glucagon secretion indirectly through CRHR2-dependent stimulation of SST secretion. Endogenous UCN-3 contributes to the acute islet response to hyperglycemia, supporting a physiologically relevant beta-cell-to-delta-cell-to-alpha-cell paracrine axis in the mouse pancreas. This pathway is disrupted following beta-cell loss, suggesting a potential contribution to impaired islet hormone regulation in diabetes.
Authors
- Daniel Bjørklund Andersen (ORCID: https://orcid.org/0000-0001-7944-9342)
- METTE MARIE ROSENKILDE (ORCID: https://orcid.org/0000-0001-9600-3254)
- Gianfranco Di Giuseppe (ORCID: https://orcid.org/0000-0003-4506-5193)
- Teresa Mezza (ORCID: https://orcid.org/0000-0001-5407-9576)
- Jens Juul Holst (ORCID: https://orcid.org/0000-0001-6853-3805)
- Jon Vergara Ucin (ORCID: https://orcid.org/0009-0004-8534-2452)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Copenhagen (DK)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.18.767593
- Primary Topic
- Pancreatic function and diabetes
- Type
- preprint
Funders
- European Foundation for the Study of Diabetes
- Novo Nordisk
- Det Sundhedsvidenskabelige Fakultet, Københavns Universitet